Torrent Pharmaceuticals lost 0.96% to Rs 808.55 at 9:17 IST on BSE as the stock turned ex-dividend today, 10 June 2013, for total dividend of Rs 17 per share for the year ended 31 March 2013.
Meanwhile, the S&P BSE Sensex was up 147.90 points or 0.76% at 19,577.13.
On BSE, 1,003 shares were traded in the counter as against average daily volume of 9,728 shares in the past one quarter.
The stock hit a high of Rs 814.95 and a low of Rs 808.55 so far during the day. The stock had hit a record high of Rs 871.80 on 3 June 2013. The stock had hit a 52-week low of Rs 580.80 on 27 June 2012.
The stock had outperformed the market over the past one month till 7 June 2013, surging 20.75% compared with the Sensex's 2.3% fall. The scrip had also outperformed the market in past one quarter, jumping 18.97% as against Sensex's 0.08% gain.
The mid-cap company has equity capital of Rs 42.31 crore. Face value per share is Rs 5.
Before turning ex-dividend, the stock offered a dividend yield of 2.08% based on the closing price of Rs 816.40 on Friday, 7 June 2013.
Torrent Pharmaceuticals reported consolidated net profit of Rs 111 crore in Q4 March 2013, as against net loss of Rs 2 crore in Q4 March 2012. Net sales rose 22.8% to Rs 803 crore in Q4 March 2013 over Q4 March 2012.
Torrent Pharmaceuticals is the flagship company of the Torrent Group. The pharmaceutical firm has focus on the therapeutics areas of diabetology, cardiovascular, central nervous system, gastro-intestinal, anti-infective, pain management and gynecology.
Powered by Capital Market - Live News
You’ve reached your limit of {{free_limit}} free articles this month.
Subscribe now for unlimited access.
Already subscribed? Log in
Subscribe to read the full story →
Smart Quarterly
₹900
3 Months
₹300/Month
Smart Essential
₹2,700
1 Year
₹225/Month
Super Saver
₹3,900
2 Years
₹162/Month
Renews automatically, cancel anytime
Here’s what’s included in our digital subscription plans
Exclusive premium stories online
Over 30 premium stories daily, handpicked by our editors


Complimentary Access to The New York Times
News, Games, Cooking, Audio, Wirecutter & The Athletic
Business Standard Epaper
Digital replica of our daily newspaper — with options to read, save, and share


Curated Newsletters
Insights on markets, finance, politics, tech, and more delivered to your inbox
Market Analysis & Investment Insights
In-depth market analysis & insights with access to The Smart Investor


Archives
Repository of articles and publications dating back to 1997
Ad-free Reading
Uninterrupted reading experience with no advertisements


Seamless Access Across All Devices
Access Business Standard across devices — mobile, tablet, or PC, via web or app
